Cargando…

Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer

BACKGROUND: Recently, the vitamin D receptor (VDR) polymorphism FokI was shown to be associated with susceptibility to ovarian cancer. We aimed to examine whether VDR FokI polymorphisms influence the survivals of patients with epithelial ovarian cancer (EOC). METHODS: VDR polymorphisms from FokI in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tamez, S, Norizoe, C, Ochiai, K, Takahashi, D, Shimojima, A, Tsutsumi, Y, Yanaihara, N, Tanaka, T, Okamoto, A, Urashima, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2777264/ https://www.ncbi.nlm.nih.gov/pubmed/19904266 http://dx.doi.org/10.1038/sj.bjc.6605414

Ejemplares similares

Serum vitamin D levels and survival of patients with colorectal cancer: Post-hoc analysis of a prospective cohort study
por: Mezawa, Hidetoshi, et al.
Publicado: (2010)

Prognostic Significance of Vitamin D Receptor Polymorphisms in Head and Neck Squamous Cell Carcinoma
por: Hama, Takanori, et al.
Publicado: (2011)

MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma
por: Hirata, Yukihiro, et al.
Publicado: (2014)

Vitamin D receptor polymorphism and prostate cancer prognosis
por: El-attar, Ahmed Z., et al.
Publicado: (2022)

Androgen receptor polymorphism, testosterone levels, and prognosis in patients with acute myocardial infarction
por: Wang, Anne, et al.
Publicado: (2021)

Association of vitamin D receptor gene polymorphisms with osteosarcoma risk and prognosis
por: Kurucu, Nilgun, et al.
Publicado: (2018)

Expression of Adiponectin Receptor-1 and Prognosis of Epithelial Ovarian Cancer Patients
por: Li, Xiahui, et al.
Publicado: (2017)

Vitamin D and VDR gene polymorphism (FokI) in epithelial ovarian cancer in Indian population
por: Mohapatra, Sudhesna, et al.
Publicado: (2013)

Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference
por: Jang, Ji Yon Agnes, et al.
Publicado: (2017)

Evidence of Differential Effects of Vitamin D Receptor Variants on Epithelial Ovarian Cancer Risk by Predicted Vitamin D Status
por: Prescott, Jennifer, et al.
Publicado: (2014)

Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer
por: Hirose, Sou, et al.
Publicado: (2018)

Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium
por: Cannioto, Rikki A, et al.
Publicado: (2016)

Circulating Vitamin D and Risk of Epithelial Ovarian Cancer
por: Arslan, Alan A., et al.
Publicado: (2009)

Somatic Copy Number Alterations Associated with Japanese or Endometriosis in Ovarian Clear Cell Adenocarcinoma
por: Okamoto, Aikou, et al.
Publicado: (2015)

Polymorphisms in the Vitamin D Receptor (VDR) and the Risk of Ovarian Cancer: A Meta-Analysis
por: Liu, Yanling, et al.
Publicado: (2013)

Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian Cancer
por: Gorringe, Kylie L., et al.
Publicado: (2010)

Dietary cadmium exposure and risk of epithelial ovarian cancer in a prospective cohort of Swedish women
por: Julin, B, et al.
Publicado: (2011)

Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma
por: Yokoyama, Y, et al.
Publicado: (2003)

Vitamin D Exposure and Ovarian Cancer Risk and Prognosis
por: L’Espérance, Kevin, et al.
Publicado: (2020)

Two Polymorphisms in the Epithelial Cell-Derived Neutrophil-Activating Peptide (ENA-78) Gene
por: Amoli, Mahsa M., et al.
Publicado: (2005)

MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma
por: Yanaihara, Nozomu, et al.
Publicado: (2016)

Expression of bone morphogenetic protein-2 and its receptors in epithelial ovarian cancer and their influence on the prognosis of ovarian cancer patients
por: Ma, Ying, et al.
Publicado: (2010)

Interactions between Serum Vitamin D Levels and Vitamin D Receptor Gene FokI Polymorphisms for Renal Function in Patients with Type 2 Diabetes
por: Yokoyama, Keitaro, et al.
Publicado: (2012)

Correlation between estrogen receptor expression and prognosis in epithelial ovarian cancer: a meta-analysis
por: Shen, Zhaojun, et al.
Publicado: (2017)

MicroRNA-34a/IL-6R pathway as a potential therapeutic target for ovarian high-grade serous carcinoma
por: Yokomizo, Ryo, et al.
Publicado: (2019)

Joint association of polymorphism of the FGFR4 gene and mutation TP53 gene with bladder cancer prognosis
por: Yang, Y C, et al.
Publicado: (2006)

Combined oral contraceptive use before the first birth and epithelial ovarian cancer risk
por: Cook, Linda S, et al.
Publicado: (2017)

The “collateral damage” of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer
por: Goenka, Luxitaa, et al.
Publicado: (2021)

High-prevalence and broad spectrum of Cell Adhesion and Extracellular Matrix gene pathway mutations in epithelial ovarian cancer
por: Rafii, Arash, et al.
Publicado: (2012)

Vitamin D receptor polymorphisms and melanoma
por: Vasilovici, Alina F., et al.
Publicado: (2019)

Cost-effectiveness of hyperthermic intraperitoneal chemotherapy at primary cytoreduction of epithelial ovarian cancer based on residual disease status
por: Penn, Courtney A., et al.
Publicado: (2022)

The polymorphism rs4705342 in the promoter of miR-143/145 is related to the risk of epithelial ovarian cancer and patient prognosis
por: Zhao, Jian, et al.
Publicado: (2023)

Vitamin D Receptor Gene Polymorphisms and Prognosis of Breast Cancer among African-American and Hispanic Women
por: Mishra, Dhruva K., et al.
Publicado: (2013)

Association of Vitamin D Receptor and Vitamin D-Binding Protein Polymorphisms with Familial Breast Cancer Prognosis in a Mono-Institutional Cohort
por: Aristarco, Valentina, et al.
Publicado: (2021)

FXYD5 is a Marker for Poor Prognosis and a Potential Driver for Metastasis in Ovarian Carcinomas
por: Raman, Pichai, et al.
Publicado: (2015)

Chemokine Receptors in Epithelial Ovarian Cancer
por: Muralidhar, Goda G., et al.
Publicado: (2013)

Anthropometric measures and epithelial ovarian cancer risk among Chinese women: results from the Shanghai Women's Health Study
por: Ma, X, et al.
Publicado: (2013)

Serum Free Fatty Acids and G-Coupled Protein Receptors Are Associated With the Prognosis of Epithelial Ovarian Cancer
por: Zhang, Lili, et al.
Publicado: (2022)

mtDNA sequence variants in subtypes of epithelial ovarian cancer stages in relation to ethnic and age difference
por: Aikhionbare, Felix O, et al.
Publicado: (2008)

Polymorphisms in NF-κB Inhibitors and Risk of Epithelial Ovarian Cancer
por: White, Kristin L, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0bjuv9eq818back6nltem6vg2t